BDRX (Biodexa Pharmaceuticals) Other Current Liabilities: $4.66 Mil (As of Dec. 2025)


BDRX Biodexa Pharmaceuticals PLC BDRX
45 GF Score
Price $2.49
View Full Analysis

What is Biodexa Pharmaceuticals Other Current Liabilities?

Biodexa Pharmaceuticals BDRX -3.86% 45 Other Current Liabilities is $4.66 Mil as of Dec. 2025. GuruFocus rates BDRX with a GF Score™ of 45/100.

Biodexa Pharmaceuticals's other current liabilities for the quarter that ended in Dec. 2025 was $4.66 Mil.

Biodexa Pharmaceuticals's quarterly other current liabilities declined from Dec. 2024 ($1.16 Mil) to Jun. 2025 ($0.77 Mil) but then increased from Jun. 2025 ($0.77 Mil) to Dec. 2025 ($4.66 Mil).

Biodexa Pharmaceuticals's annual other current liabilities declined from Dec. 2023 ($5.27 Mil) to Dec. 2024 ($1.16 Mil) but then increased from Dec. 2024 ($1.16 Mil) to Dec. 2025 ($4.66 Mil).

Biodexa Pharmaceuticals Other Current Liabilities Related Terms

Biodexa Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Biodexa Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodexa Pharmaceuticals Other Current Liabilities Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.36 5.27 1.16 4.66

Biodexa Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.27 2.06 1.16 0.77 4.66
BDRX
45GF Score
Biodexa Pharmaceuticals PLC BDRX
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biodexa Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $4.66 Mil mean?
Biodexa Pharmaceuticals (BDRX) has a Other Current Liabilities of $4.66 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Biodexa Pharmaceuticals.
Is Biodexa Pharmaceuticals' Other Current Liabilities too high?
Biodexa Pharmaceuticals' current Other Current Liabilities is $4.66 Mil. Overall, Biodexa Pharmaceuticals has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Biodexa Pharmaceuticals' Other Current Liabilities compare to ADTX and AAGH?
Biodexa Pharmaceuticals' Other Current Liabilities of $4.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Biodexa Pharmaceuticals. Biodexa Pharmaceuticals's current Other Current Liabilities is $4.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biodexa Pharmaceuticals stock overvalued right now?
Biodexa Pharmaceuticals (BDRX) has a current Other Current Liabilities of $4.66 Mil. The current Other Current Liabilities is $4.66 Mil. Biodexa Pharmaceuticals' overall GF Score™ is 45/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Biodexa Pharmaceuticals (BDRX), the current Other Current Liabilities is $4.66 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biodexa Pharmaceuticals Business Description

Address 1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
45GF Score

Get the complete analysis for BDRX

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.49
Price